Sector Gamma ASA »

Travere Therapeutics shares owned by Sector Gamma ASA

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Sector Gamma ASA from 13F filings

Historical chart of Sector Gamma ASA investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Sector Gamma ASA

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.5M 80k 56.81

More positions owned by Sector Gamma ASA

Bristol Myers Squibb (BMY)
Merck & Co (MRK)
Medtronic SHS (MDT)
Pfizer (PFE)
Incyte Corporation (INCY)
Anthem (ELV)
BioMarin Pharmaceutical (BMRN)
Thermo Fisher Scientific (TMO)
CVS Caremark Corporation (CVS)
Iqvia Holdings (IQV)
Ionis Pharmaceuticals (IONS)
Becton, Dickinson and (BDX)
Abbott Laboratories (ABT)
Ge Healthcare Technologies I Common Stock (GEHC)
Zimmer Holdings (ZBH)

View all positions for Sector Gamma ASA

Top funds holding Travere Therapeutics

Henderson Group
Jupiter Topco
BlackRock
FMR
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Perceptive Advisors
Nomura Asset Management International
Adage Capital Partners GP
Geode Capital Management
Rock Springs Capital Management
Armistice Capital
Kynam Capital Management
Stephens Investment Management Group

View all funds holding Travere Therapeutics